BioMedical SIG #9

BioMedical SIG #9

Join the next BioMedical SIG webinar to discover The Venture Builder Model: Turning IP into Impact.

Book Your Place

This event has now expired

Turning groundbreaking biotech research into real-world solutions is often hindered by the infamous “valley of death” — the critical gap where funding is scarce, risk is high, and startups often fail to take shape. We will explore how the venture builder model can play a transformative role in bridging that gap and accelerating the path from lab bench to market.

In this session, we will discover:

  • Why the valley of death is especially deep in biotech — and what it takes to cross it
  • How venture builders provide the structure, resources, and expertise needed to de-risk academic IP
  • Case studies of successful biotech startups launched from university research
  • Practical strategies for TTOs to partner with venture builders and boost commercialization outcomes

This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.

Booking Options

  • Are you an ASTP Member?

  • By proceeding with this booking, you are agreeing to allow ASTP to use your image solely for promotional and educational purposes.

Testimonials

testimonial

One very long and hard day, but very useful for my work in TTO.

Petr Kubečka

Palacký University Olomouc, Czech Republic

testimonial

ASTP has attained a unique position that has turned it into a highly valued player on the global technology transfer scene.

Koenraad Debackere

KU Leuven, Belgium

testimonial

Fruitful discussion.

Cecile Henrich-Burkhardt

Technical University of Munich, Germany

testimonial

ASTP brought the right structure and terminology to my knowledge of technology licensing.

René Widmer

ETH Transfer, Switzerland

testimonial

Always simply inspiring! That is ASTP.

Filip Auinger

Palacký University Olomouc, Czech Republic